Zobrazeno 1 - 10
of 290
pro vyhledávání: '"TR Golub"'
Autor:
TW McLean, S Ringold, D Neuberg, K Stegmaier, R Tantravahi, J Ritz, HP Koeffler, S Takeuchi, JW Janssen, T Seriu, CR Bartram, SE Sallan, DG Gilliland, TR Golub
Publikováno v:
Blood. 88:4252-4258
Polymerase chain reaction-based screening of childhood acute lymphoblastic leukemia (ALL) samples showed that a TEL/AML1 fusion transcript was detected in 27% of all cases, representing the most common known gene rearrangement in childhood cancer. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25c1e3f52274820409dae16346db1a33
https://doi.org/10.1182/blood.v88.11.4252.bloodjournal88114252
https://doi.org/10.1182/blood.v88.11.4252.bloodjournal88114252
Autor:
Rauh U; Trueline Therapeutics Inc., Cambridge, MA, USA. ulla@truelinetx.com., Wei G; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Serrano-Wu M; Anji Pharmaceuticals Inc., Cambridge, MA, USA., Kosmidis G; Ncardia, Leiden, The Netherlands., Kaulfuss S; Nuvisan Innovation Campus Berlin, Berlin, Germany., Siegel F; Bayer AG R&D, Berlin, Germany., Thede K; Nuvisan Innovation Campus Berlin, Berlin, Germany., McFarland J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lemke CT; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Werbeck N; Bayer AG R&D, Berlin, Germany., Nowak-Reppel K; Nuvisan Innovation Campus Berlin, Berlin, Germany., Pilari S; Independent Consultant, Pharmacometrics Modeling and Simulation, Berlin, Germany., Menz S; Bayer AG R&D, Berlin, Germany., Ocker M; Trueline Therapeutics Inc., Cambridge, MA, USA., Zhang W; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Davis K; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Poncet-Montange G; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Roth J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Daniels D; Trueline Therapeutics Inc., Cambridge, MA, USA., Kaushik VK; Trueline Therapeutics Inc., Cambridge, MA, USA., Hubbard B; Anji Pharmaceuticals Inc., Cambridge, MA, USA., Ziegelbauer K; Almirall R&D, Sant Feliu de Llobregat, Spain., Golub TR; Broad Institute of MIT and Harvard, Cambridge, MA, USA. golub@broadinstitute.org.; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. golub@broadinstitute.org.
Publikováno v:
Nature cancer [Nat Cancer] 2024 Oct; Vol. 5 (10), pp. 1479-1493. Date of Electronic Publication: 2024 Aug 23.
Autor:
Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, Thirza Campbell K, Sellers WR, Roberts TM, Loda M, Golub TR, Hahn WC
Publikováno v:
Cancer research [Cancer Res] 2024 Aug 01; Vol. 84 (15), pp. 2561.
Autor:
Martin-Alonso C; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Harvard-MIT Division of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Tabrizi S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA., Xiong K; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Blewett T; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Sridhar S; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Crnjac A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Patel S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Division of Pulmonary and Critical Care, Department of Medicine, Massachusetts General Hospital, Boston, MA 02124, USA., An Z; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Bekdemir A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Shea D; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Wang ST; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Rodriguez-Aponte S; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Naranjo CA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Rhoades J; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Kirkpatrick JD; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Harvard-MIT Division of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Fleming HE; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Amini AP; Microsoft Research, Cambridge, MA 02142, USA., Golub TR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Harvard Medical School, Boston, MA 02115, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Love JC; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Bhatia SN; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Harvard-MIT Division of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.; Wyss Institute at Harvard University, Boston, MA 02215, USA.; Howard Hughes Medical Institute, Cambridge, MA 02138, USA., Adalsteinsson VA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 Jan 19; Vol. 383 (6680), pp. eadf2341. Date of Electronic Publication: 2024 Jan 19.
Autor:
Hofman DA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Ruiz-Orera J; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany., Yannuzzi I; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Murugesan R; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Brown A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Clauser KR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Condurat AL; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., van Dinter JT; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Engels SAG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Goodale A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Abid T; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Wang L; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Zhou KN; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Vogelzang J; Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA., Ligon KL; Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA; Department of Pathology, Boston Children's Hospital, Boston MA 02115, USA., Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45229, USA., Roth JA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Hubner N; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany; Charité-Universitätsmedizin, 10117 Berlin, Germany; German Centre for Cardiovascular Research, Partner Site Berlin, 13347 Berlin, Germany., Golub TR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., Bandopadhayay P; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., van Heesch S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands. Electronic address: s.vanheesch@prinsesmaximacentrum.nl., Prensner JR; Department of Pediatrics, Division of Pediatric Hematology/Oncology and Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: prensner@umich.edu.
Publikováno v:
Molecular cell [Mol Cell] 2024 Jan 18; Vol. 84 (2), pp. 261-276.e18. Date of Electronic Publication: 2024 Jan 03.
Autor:
Parsons HA; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston. Electronic address: Heather_Parsons@dfci.harvard.edu., Blewett T; Broad Institute of MIT and Harvard, Cambridge., Chu X; Data Science, Dana-Farber Cancer Institute, Boston., Sridhar S; Broad Institute of MIT and Harvard, Cambridge., Santos K; Medical Oncology, Dana-Farber Cancer Institute, Boston., Xiong K; Broad Institute of MIT and Harvard, Cambridge., Abramson VG; Vanderbilt-Ingram Cancer Center, Nashville., Patel A; Medical Oncology, Dana-Farber Cancer Institute, Boston., Cheng J; Broad Institute of MIT and Harvard, Cambridge., Brufsky A; University of Pittsburgh School of Medicine, Pittsburgh., Rhoades J; Broad Institute of MIT and Harvard, Cambridge., Force J; Duke Cancer Center, Durham., Liu R; Broad Institute of MIT and Harvard, Cambridge., Traina TA; Memorial Sloan Kettering Cancer Center, New York., Carey LA; The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill., Rimawi MF; Baylor College of Medicine Dan L. Duncan Comprehensive Cancer Center, Houston., Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis., Stearns V; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore., Specht J; Seattle Cancer Care Alliance, Seattle., Falkson C; The University of Alabama at Birmingham, Birmingham., Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston., Wolff AC; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore., Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston., Tayob N; Data Science, Dana-Farber Cancer Institute, Boston., Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston., Makrigiorgos GM; Radiation Oncology, Dana-Farber Cancer Institute, Boston, USA., Golub TR; Broad Institute of MIT and Harvard, Cambridge., Mayer EL; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston. Electronic address: Erica_Mayer@dfci.harvard.edu., Adalsteinsson VA; Broad Institute of MIT and Harvard, Cambridge. Electronic address: viktor@broadinstitute.org.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Oct; Vol. 34 (10), pp. 899-906. Date of Electronic Publication: 2023 Aug 18.
Autor:
Baumgartner CK; AbbVie, North Chicago, IL, USA. christina.baumgartner@abbvie.com., Ebrahimi-Nik H; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Ohio State University Comprehensive Cancer Center and Pelotonia Institute for Immuno-Oncology, Columbus, OH, USA., Iracheta-Vellve A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Pfizer, Groton, CT, USA., Hamel KM; AbbVie, North Chicago, IL, USA., Olander KE; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Davis TGR; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., McGuire KA; AbbVie, North Chicago, IL, USA., Halvorsen GT; AbbVie, North Chicago, IL, USA., Avila OI; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Patel CH; Calico Life Sciences, South San Francisco, CA, USA., Kim SY; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Kammula AV; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Muscato AJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Halliwill K; AbbVie, South San Francisco, CA, USA., Geda P; AbbVie, North Chicago, IL, USA.; Bristol Myers Squibb, Summit, NJ, USA., Klinge KL; AbbVie, North Chicago, IL, USA., Xiong Z; AbbVie, North Chicago, IL, USA.; Ipsen Biosciences, Cambridge, MA, USA., Duggan R; AbbVie, North Chicago, IL, USA., Mu L; AbbVie, North Chicago, IL, USA., Yeary MD; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Patti JC; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Balon TM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Mathew R; AbbVie, South San Francisco, CA, USA., Backus C; AbbVie, South San Francisco, CA, USA., Kennedy DE; AbbVie, North Chicago, IL, USA., Chen A; AbbVie, North Chicago, IL, USA., Longenecker K; AbbVie, North Chicago, IL, USA., Klahn JT; AbbVie, North Chicago, IL, USA., Hrusch CL; AbbVie, North Chicago, IL, USA., Krishnan N; AbbVie, North Chicago, IL, USA.; Monte Rosa Therapeutics, Boston, MA, USA., Hutchins CW; AbbVie, North Chicago, IL, USA., Dunning JP; AbbVie, North Chicago, IL, USA., Bulic M; AbbVie, North Chicago, IL, USA., Tiwari P; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Colvin KJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Chuong CL; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Kohnle IC; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Rees MG; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Boghossian A; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ronan M; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Roth JA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wu MJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Suermondt JSMT; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Knudsen NH; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Cheruiyot CK; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Sen DR; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Griffin GK; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Golub TR; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., El-Bardeesy N; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Decker JH; AbbVie, North Chicago, IL, USA., Yang Y; AbbVie, North Chicago, IL, USA., Guffroy M; AbbVie, North Chicago, IL, USA., Fossey S; AbbVie, North Chicago, IL, USA., Trusk P; AbbVie, North Chicago, IL, USA., Sun IM; Calico Life Sciences, South San Francisco, CA, USA., Liu Y; Calico Life Sciences, South San Francisco, CA, USA., Qiu W; AbbVie, North Chicago, IL, USA., Sun Q; AbbVie, North Chicago, IL, USA., Paddock MN; Calico Life Sciences, South San Francisco, CA, USA., Farney EP; AbbVie, North Chicago, IL, USA., Matulenko MA; AbbVie, North Chicago, IL, USA., Beauregard C; Calico Life Sciences, South San Francisco, CA, USA.; Vir Biotechnology, San Francisco, CA, USA., Frost JM; AbbVie, North Chicago, IL, USA. jennifer.frost@abbvie.com., Yates KB; Broad Institute of MIT and Harvard, Cambridge, MA, USA. yates@broadinstitute.org.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. yates@broadinstitute.org., Kym PR; AbbVie, North Chicago, IL, USA. phil.r.kym@abbvie.com., Manguso RT; Broad Institute of MIT and Harvard, Cambridge, MA, USA. rmanguso@mgh.harvard.edu.; Center for Cancer Research and Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. rmanguso@mgh.harvard.edu.
Publikováno v:
Nature [Nature] 2023 Oct; Vol. 622 (7984), pp. 850-862. Date of Electronic Publication: 2023 Oct 04.
Autor:
Dreishpoon MB; Broad Institute of Harvard and MIT, Cambridge, USA., Bick NR; Broad Institute of Harvard and MIT, Cambridge, USA., Petrova B; Harvard Medical School, Boston, Massachusetts, USA; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA., Warui DM; Department of Chemistry and Biochemistry and Molecular Biology and the Howard Hughes Medical Institute, The Pennsylvania State University, State College, Pennsylvania, USA., Cameron A; Broad Institute of Harvard and MIT, Cambridge, USA., Booker SJ; Department of Chemistry and Biochemistry and Molecular Biology and the Howard Hughes Medical Institute, The Pennsylvania State University, State College, Pennsylvania, USA., Kanarek N; Broad Institute of Harvard and MIT, Cambridge, USA; Harvard Medical School, Boston, Massachusetts, USA; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA., Golub TR; Broad Institute of Harvard and MIT, Cambridge, USA; Harvard Medical School, Boston, Massachusetts, USA; Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Tsvetkov P; Broad Institute of Harvard and MIT, Cambridge, USA. Electronic address: ptsvetko@broadinstitute.org.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2023 Sep; Vol. 299 (9), pp. 105046. Date of Electronic Publication: 2023 Jul 13.
Autor:
Krill-Burger JM; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Dempster JM; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Borah AA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Paolella BR; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Root DE; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Golub TR; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Boehm JS; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Hahn WC; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., McFarland JM; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Vazquez F; Broad Institute of Harvard and MIT, Cambridge, MA, USA. vazquez@broadinstitute.org.; Dana-Farber Cancer Institute, Boston, MA, USA. vazquez@broadinstitute.org., Tsherniak A; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Publikováno v:
Genome biology [Genome Biol] 2023 Aug 23; Vol. 24 (1), pp. 192. Date of Electronic Publication: 2023 Aug 23.
Autor:
Hofman DA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; These authors contributed equally., Ruiz-Orera J; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.; These authors contributed equally., Yannuzzi I; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Murugesan R; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Brown A; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Current address: Arbor Biotechnologies, Cambridge, MA, 02140, USA., Clauser KR; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Condurat AL; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., van Dinter JT; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands., Engels SAG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands., Goodale A; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands., Abid T; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Wang L; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Zhou KN; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Current address: Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, 91101, USA., Vogelzang J; Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02215, USA., Ligon KL; Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02215, USA.; Department of Pathology, Boston Children's Hospital, Boston MA 02115., Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, 45229, USA., Roth JA; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Hubner N; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.; Charité-Universitätsmedizin, 10117 Berlin, Germany.; German Centre for Cardiovascular Research, Partner Site Berlin, 13347 Berlin, Germany., Golub TR; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA., Bandopadhayay P; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA., van Heesch S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands., Prensner JR; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA.; Current address: Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 May 06. Date of Electronic Publication: 2023 May 06.